|
Abstract [Obj ective]To explore the efficacy of clinical pathway in the treatment of patients with perito-neal dialysis-related peritonitis.[Methods]Totally 49 patients with peritoneal dialysis-related peritonitis who were enrolled into clinical pathway in our department from July 2012 to July 2013 and 49 patients with perito-neal dialysis-related peritonitis patients who were not enrolled into clinical pathway from June 2011 to June 2012 were investigated.The positive rate of dialysate culture,the time of dialysate into clear liquid,hospital day,hospitalization expensens and recurrence in two groups were observed and compared.[Results]There was no significant difference in clinical indexes between two groups before treatment.The positive rate of dialysate culture in the experiment group was slightly higher than that in control group,but there was no significant difference between two groups(P>0.05).The time of dialysate turning better or normal in experiment group was lower than that in control group.Compared with the control group,the hospital day,per capita hospitali-zation expenses and the recurrence of peritonitis in experiment group were markedly decreased,and there were significant differences between two groups(P<0.05).[Conclusion]Clinical pathway in the treatment of per-itoneal dialysis-related peritonitis can promote clinical improvement,reduce hospital day and hospitalization ex-penses and decrease the recurrence of peritonitis.Therefore,it is worthy of clinical promotion.
|
|
|
|
|
|
2014, Vol. 31 
